【摘要】目的: 探讨单独应用抗抑郁药治疗功能性消化不良( FD )的疗效及安全性。方法:将184例病程>1年的功能性消化不良患者,随机分为3组,甲组62例单独给予抗抑郁药治疗,乙组60例应用内科常规治疗(抑酸药和/或促胃动力药)、丙组62例给予乙组治疗+抗抑郁药联合治疗,治疗时间均为12周。以自制FD症状评定量表(FDSR)、汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)评定疗效,以副反应量表(TFSS)评定副反应。结果:治疗12周末甲乙丙3组有效率分别为90.32%(56)、51.66%(31)、91.93%(57),3组患者在12周末均有显著疗效(P<0.01)甲丙两组间疗效差异无显著性(P>0.05),两组与乙组比较差异有显著性(P<0.01)。3组间不良反应均少而轻,组间比较差异无显著性(P>0.05)。结论:单独应用抗抑郁药能有效治疗FD,且不良反应少而轻。
【关键词】 功能性消化不良; 抗抑郁药; 疗效;
A comparative study of Motion stimulant in treatment of functional dyspepsia
【abstract】 Objective: To evaluate the effects of various treatment on patients with functional dyspepsia (FD). Methods: 184 out-patients with FD were divided into 3 groups: A-group (n=62), which received routine medicine treatment-group (n=60), which was given psycho pharmaceutical treatment including antidepressants, anxiolytics and antipsychotic-group (n=62), which was given psycho pharmaceutical treatment pulsing psychotherapy. They were all observed for 3 months, and were all assessed by HAMD and HAMA.Results: the effect of the treatment: A-group =C-group >B-group. Conclusions: To treat of FD, the prescription of psycho pharmaceutical treatment pulsing psychotherapy is the finest in the plans, with little and side effects.
【Key words】 Functional dyspepsia; Motion stimulant; Effectiveness
功能性消化不良(functional dyspepsia,FD)是常见的消化系统疾病之一,其病因及发病机制均有待明确。实际上绝大多数FD均可按照中国精神障碍与诊断标准第三版(CCMD-3)诊断为神经症中的躯体形式障碍,即躯体形式自主神经紊乱中高位和低位胃肠功能紊乱共同组成的疾病类型[1],过去称为胃肠神经官能症。由于FD患者具有神经症躯体形式障碍的基本特点,又常伴有焦虑和抑郁等情绪障碍[2],应用内科常规治疗往往难以获得满意
| 相关热词搜索 |
